FDA Inspection
Etex CorporationEtex Corporation – FDA Inspection, May 23, 2019
Record Details
This FDA Inspection record concerns Etex Corporation, with an inspection on May 23, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 51c7b4dc-71b0-4c2b-bd64-631f8da793f9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1090850
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.55(a)(3)Summary--records used to make determination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Etex Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2024 | Not classified | New England District Office | |
| July 16, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 19, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 15, 2013 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 29, 2010 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Etex Corporation
- FDA Inspection 1250621 - 2024-09-25
- FDA Inspection 1059083 - 2018-07-16
- FDA Inspection 891810 - 2014-08-19
- FDA Inspection 819226 - 2013-02-15
- FDA Inspection 680526 - 2010-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.